Definium Therapeutics (DFTX) director granted RSUs and stock options in equity award
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Definium Therapeutics director Roger Adsett reported equity awards consisting of 3,555 common shares in the form of restricted stock units and 14,620 stock options. The options carry an exercise price of $24.11 per share and expire on June 10, 2036.
Both the RSUs and options vest as to 1/12 of the underlying shares on each monthly anniversary of the grant date, with any remaining unvested portion vesting immediately before the issuer’s next annual meeting if it occurs before the first anniversary, subject to his continued service. Following these grants, Adsett holds 3,555 common shares and 14,620 options directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
Adsett Roger
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 14,620 | $0.00 | -- |
| Grant/Award | Common Shares | 3,555 | $0.00 | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 14,620 shares (Direct, null);
Common Shares — 3,555 shares (Direct, null)
Footnotes (1)
- These shares represent restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one common share of the Issuer. The RSUs vest as to 1/12th of the underlying shares on each monthly anniversary of the date of the grant, provided, that if the Issuer's annual meeting immediately following the date of grant takes place prior to the first anniversary of the date of grant, any unvested RSUs will vest immediately prior to the Issuer's annual meeting following the date of grant, subject the Reporting Person's continued service through the applicable vesting date. The Stock Option vests and becomes exercisable as to 1/12th of the underlying shares on each monthly anniversary of the date of the grant, provided, that if the Issuer's annual meeting immediately following the date of grant takes place prior to the first anniversary of the date of grant, the Stock Option will vest and become exercisable immediately prior to the Issuer's annual meeting following the date of grant, subject to the Reporting Person's continued service through the applicable vesting date.
Key Figures
RSU grant size: 3,555 shares
Option grant size: 14,620 options
Option exercise price: $24.11 per share
+3 more
6 metrics
RSU grant size
3,555 shares
Restricted stock units granted to director Roger Adsett
Option grant size
14,620 options
Stock options granted to acquire common shares
Option exercise price
$24.11 per share
Conversion or exercise price for stock options
Option expiration
June 10, 2036
Expiration date of stock options
Shares held after grant
3,555 shares
Total common shares directly held following RSU award
Options held after grant
14,620 options
Total stock options directly held following award
Key Terms
restricted stock units ("RSUs"), Stock Option, vest, exercise price, +1 more
5 terms
restricted stock units ("RSUs") financial
"These shares represent restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one common share"
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
Stock Option financial
"The Stock Option vests and becomes exercisable as to 1/12th of the underlying shares"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
vest financial
"The RSUs vest as to 1/12th of the underlying shares on each monthly anniversary of the date of the grant"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
exercise price financial
"conversion_or_exercise_price": "24.1100""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
annual meeting financial
"any unvested RSUs will vest immediately prior to the Issuer's annual meeting following the date of grant"
A company's annual meeting is a yearly gathering where owners (shareholders) and the board review performance, ask questions, and vote on key matters like electing directors, approving auditor choices, and sometimes setting pay or dividend policies. For investors it matters because decisions made and votes cast can change who runs the company, influence strategy and payouts, and affect the value or direction of their investment—similar to a homeowners’ meeting where rules and leaders that shape your property’s value are decided.
FAQ
What insider transactions did DFTX director Roger Adsett report on this Form 4?
Roger Adsett reported receiving 3,555 restricted stock units and 14,620 stock options in Definium Therapeutics, Inc. These awards are compensation-related equity grants, not open‑market purchases or sales, and increase his direct equity-based exposure to the company.
What are the key terms of Roger Adsett’s stock options in Definium Therapeutics (DFTX)?
Adsett’s stock options cover 14,620 underlying common shares at an exercise price of $24.11 per share and expire on June 10, 2036. The options vest in monthly installments, subject to his continued service with the company.
How do the RSUs granted to Roger Adsett by Definium Therapeutics (DFTX) vest?
The 3,555 RSUs vest as to 1/12 of the underlying shares each month after the grant date. If the next annual meeting occurs before the first anniversary, any remaining unvested RSUs vest immediately before that meeting, assuming continued service.
Are Roger Adsett’s Form 4 transactions in DFTX open‑market buys or sells?
No, the Form 4 shows grant or award acquisitions, not market trades. Both the RSUs and stock options were awarded as compensation, with no purchase price paid for the shares or options at the time of grant.